The Clonal Distribution and Diversity of Extraintestinal Escherichia coli Isolates Vary According to Patient Characteristics

Escherichia coli Sequence Type 131 Is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts

(2013) Ritu Banerjee et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli

(2013) James R. Johnson et al.   JOURNAL OF INFECTIOUS DISEASES

Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) andblaCTX-M-15among Extended-Spectrum-β-Lactamase-Producing E. coli from the United States, 2000 to 2009

(2012) James R. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clonal Composition and Community Clustering of Drug-Susceptible and -Resistant Escherichia coli Isolates from Bloodstream Infections

(2012) Sheila Adams-Sapper et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-Resolution Two-Locus Clonal Typing of Extraintestinal Pathogenic Escherichia coli

(2012) Scott J. Weissman et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Phylogenetic Distribution of CTX-M- and Non-Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates: Group B2 Isolates, Except Clone ST131, Rarely Produce CTX-M Enzymes

(2012) S. Brisse et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings

(2011) G. Croxall et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England

(2011) T. M. Gibreel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals

(2010) Gisele Peirano et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia

(2010) J. L. Platell et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

(2009) J. R. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15

(2009) Miguel Blanco et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Three-Decade Epidemiological Analysis of Escherichia coli O15:K52:H1

(2009) B. Olesen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis

(2008) S. Cagnacci et al.   JOURNAL OF CLINICAL MICROBIOLOGY